ACTIVITIES OF 3 INVESTIGATIONAL FLUOROQUINOLONES (BAY-Y-3118, DU-6859A, AND CLINAFLOXACIN) AGAINST NEISSERIA-GONORRHOEAE ISOLATES WITH DIMINISHED SUSCEPTIBILITIES TO CIPROFLOXACIN AND OFLOXACIN

被引:16
作者
CARLYN, CJ [1 ]
DOYLE, LJ [1 ]
KNAPP, CC [1 ]
LUDWIG, MD [1 ]
WASHINGTON, JA [1 ]
机构
[1] CLEVELAND CLIN FDN,DEPT CLIN PATHOL,MICROBIOL SECT,CLEVELAND,OH 44195
关键词
D O I
10.1128/AAC.39.7.1606
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Between 1 January 1992 and 31 December 1993, our laboratory, as part of the Gonococcal Isolate Surveillance Project, found that 39 of 673 isolates of Neisseria gonorrhoeae from one local sexually transmitted diseases clinic demonstrated decreased susceptibilities to both ciprofloxacin and ofloxacin. The MICs of BAY y 3118, DU-6859a, and clinafloxacin at which 90% of the gonococci with decreased susceptibility to ciprofloxacin and ofloxacin were inhibited were ah 0.016 mu g/ml, which was eightfold higher than those for ciprofloxacin-susceptible gonococci. Our report substantiates prior observations that diminished susceptibility to one quinolone is often associated with diminished susceptibility to other quinolones.
引用
收藏
页码:1606 / 1608
页数:3
相关论文
共 18 条
[1]  
[Anonymous], 1993, M7A3 NAT COMM CLIN L
[2]  
BOGGAERTS J, 1993, GENITOURIN MED, V69, P196
[3]   ORAL CIPROFLOXACIN VERSUS CEFTRIAXONE FOR THE TREATMENT OF URETHRITIS FROM RESISTANT NEISSERIA-GONORRHOEAE IN ZAMBIA [J].
BRYAN, JP ;
HIRA, SK ;
BRADY, W ;
LUO, N ;
MWALE, C ;
MPOKO, G ;
KRIEG, R ;
SIWIWALIONDO, E ;
REICHART, C ;
WATERS, C ;
PERINE, PL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :819-822
[4]   INVITRO ANTIBIOTIC SUSCEPTIBILITIES OF NEISSERIA-GONORRHOEAE ISOLATES IN THE PHILIPPINES [J].
CLENDENNEN, TE ;
HAMES, CS ;
KEES, ES ;
PRICE, FC ;
RUEPPEL, WJ ;
ANDRADA, AB ;
ESPINOSA, GE ;
KABRERRA, G ;
WIGNALL, FS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (02) :277-282
[5]   INTERPRETIVE CRITERIA FOR SUSCEPTIBILITY TESTING OF CI-960 (PD127391, AM-1091), FLEROXACIN, LOMEFLOXACIN, AND TEMAFLOXACIN AGAINST NEISSERIA-GONORRHOEAE, INCLUDING DRUG STABILITY IN GC AGAR MEDIUM [J].
ERWIN, ME ;
JONES, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (05) :1170-1173
[6]   IN-VITRO ACTIVITY OF BAY Y-3118, A NEW QUINOLONE [J].
FASS, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2348-2357
[7]   PROPOSED INTERPRETIVE CRITERIA AND QUALITY-CONTROL PARAMETERS FOR TESTING INVITRO SUSCEPTIBILITY OF NEISSERIA-GONORRHOEAE TO CIPROFLOXACIN [J].
FUCHS, PC ;
BARRY, AL ;
BAKER, C ;
MURRAY, PR ;
WASHINGTON, JA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (10) :2111-2114
[8]  
Gorwitz Rachel J., 1993, Morbidity and Mortality Weekly Report, V42, P29
[9]   4-QUINOLONE-RESISTANT NEISSERIA-GONORRHOEAE IN THE UNITED-KINGDOM [J].
GRANSDEN, WR ;
WARREN, C ;
PHILLIPS, I .
JOURNAL OF MEDICAL MICROBIOLOGY, 1991, 34 (01) :23-27
[10]   COMPARISON OF CIPROFLOXACIN AND CEFTRIAXONE AS SINGLE-DOSE THERAPY FOR UNCOMPLICATED GONORRHEA IN WOMEN [J].
HOOK, EW ;
JONES, RB ;
MARTIN, DH ;
BOLAN, GA ;
MROCZKOWSKI, TF ;
NEUMANN, TM ;
HAAG, JJ ;
ECHOLS, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1670-1673